Glass Jacobson Investment Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$697	Buy	+19	New	+$751	﹤0.01%	768

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Glass Jacobson Investment Advisors's SYNH Position: Q4 2022 in Review

Glass Jacobson Investment Advisors opened a new position in Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022: 19 shares worth $697. The stake represents ﹤0.01% of the portfolio and ranks #768 among its holdings.

307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Glass Jacobson Investment Advisors held 19 shares of Syneos Health, Inc. Class A Common Stock worth $697 as of Q4 2022.
Syneos Health, Inc. Class A Common Stock was a new Glass Jacobson Investment Advisors position in Q4 2022.
Syneos Health, Inc. Class A Common Stock made up ﹤0.01% of Glass Jacobson Investment Advisors's portfolio in Q4 2022, its #768 holding.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Glass Jacobson Investment Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.